The US Food & Drug Administration refused to review Moderna’s mRNA flu vaccine this week. Regulators had already shaken up the industry by requiring new safety warnings and don’t appear to be on track ...
This year's fierce flu season is not over. Although parts of the United States are seeing downward trends, influenza activity remains elevated nationally. The 2025-2026 flu season is already shaping ...